A senior-level tenured neuroscientist at the Salk Institute for Biological Studies in La Jolla, Calif., is teetering on the edge of closing his lab after Salk administrators pulled hundreds of thousands of dollars in funding that was tied to a dwindling endowment.
linkurl:Stephen Heinemann;http://www.salk.edu/faculty/heinemann.html has seen tough financial times. As president of the linkurl:Society for Neuroscience;http://www.sfn.org/ in 2005-06, he had a front-row seat in Washington to watch the NIH budget flatline. Expecting diminishing grant payments, he gradually shrunk his lab from a staff of more than 40 around a decade ago to a dozen or so researchers today. Then the economy tanked, and in January Salk halted all funding stemming from the Salk Institute Council Endowment, which supported Heinemann's endowed chair position and a sizeable chunk of his research. Heinemann still held two grants from the NIH and received support from a private foundation. But with an active mouse research...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?